Search
for
Sort by
Research 151–180 of 1000+
- Type-2 immunity associated with type-1 related skin inflammatory diseases: friend or foe?
- 1326 Translation-dependent skin hyperplasia is promoted by type 1/17 inflammation in psoriasis
- 1117 PX-12 inhibits NLRP3 inflammasome activation to treat psoriasis
- Free Testosterone Levels in Patients with Covid-19 and its Association with Disease Severity
- Increased expression of nerve growth factor and neurokinin-1 alarm the hair loss in female with trichodynia
- Elevated serum heat shock protein-70 and interleukin-15: prognostic biomarkers correlating with clinical severity and diagnostic efficacy in active alopecia areata
- Detection of Serum Levels of Interleukins-17, 21, 6 and Tumor Necrosis Factor-α in Patients with Patchy Alopecia Areata and Their Association with Disease Severity
- Immunoglobulin E and Serum Interleukin-13 and Bacteria in Patients with Alopecia Areata
- Exogenous IL-27 prevents the development of alopecia areata
- MicroRNA-1246 Inhibits NFATc1 Phosphorylation and Regulates T Helper 17 Cell Activation in the Pathogenesis of Severe Alopecia Areata
- Increased serum interleukin-17A levels correlate with disease severity and poor prognostic factors in patients with alopecia areata
- Serum Level of Interleukin 17 in Alopecia Areata Patients and Its Relation with the Severity of the Disease: a Case Control Study
- 1315 An Integrated model of alopecia areata biomarkers highlights both Th1/Th2 upregulation, with stronger correlations between Th2 activation and disease severity
- Skin-infiltrating CD4+ lymphoma cells depend on hair follicle-derived IL-7
- Serum Interleukin 18 and NLRP3 in patients with Alopecia Areata
- LB1048 Effectiveness of OR-101 in a murine model of atopic dermatitis
- 006 Exogenous IL-27 promotes immunosuppressive T cells and prevents the development of alopecia areata in C3H/HeJ mice
- Interleukin‐13 as a promising therapeutic target for alopecia areata associated with atopic dermatitis
- 42905 Role of regulatory T and T-helper 17 cells in patients with acute diffuse and total alopecia
- Serum Interleukin 17 in Patients with Pattern Hair Loss
- 177 Chronic graft-versus-host disease exhibits distinct Th1-skewing and barrier abnormalities in the skin
- 1617 Impact of type 2 cytokines on the keratinocytes-s. aureus interaction
- 224 Humoral immune response to COVID-19 vaccination in psoriasis patients on biologic therapy is impaired compared to healthy controls
- Serum Interleukin 17 as a Marker for Alopecia Areata Severity: A Case-Control Study
- Interleukin 15 Gene Polymorphism in patients with Alopecia Areata
- 061 Selective inhibition of tyrosine kinase 2 prevents and restores interleukin-12-induced hair follicle immune privilege collapse: a novel approach to alopecia areata therapy?
- Serum Interleukin 19 in Patients with Alopecia Areata
- Alopesi areata hastalarında serum interferon-gama, tümör nekrozis faktör-alfa, interlökin-13, interlökin-17 ve transforming growth faktör-beta düzeylerinin değerlendirilmesi
- Hair Growth Promoting Effects of 15-Hydroxyprostaglandin Dehydrogenase Inhibitor in Human Follicle Dermal Papilla Cells
- Cortexolone 17α-Propionate (Clascoterone) is an Androgen Receptor Antagonist in Dermal Papilla Cells In Vitro